New insights from continuous glucose monitoring into the route to diabetes

ConclusionsCGMS allows for a better T2DM risk‐development categorization than fasting glucose and HbA1c in a high‐risk population. CGMS‐derived phenotyping reveals clinical differences, not disclosed by conventional FPG/HbA1c categorization. These differences may correlate with distinct pathophysiological mechanisms.
Source: Diabetes/Metabolism Research and Reviews - Category: Endocrinology Authors: Tags: RESEARCH ARTICLE Source Type: research